Infection prevention and contract sterilization
STERIS plc
STERIS sells sterilization equipment, consumables, and maintenance services to healthcare providers and provides contract sterilization and testing to medical-device and pharmaceutical manufacturers. Its operations depend on critical inputs such as cobalt-60 and ethylene oxide, manufacturing components, and production-management software.
Business categories Medical Devices & Supplies · Biopharma & Life Sciences · primary
STE Updated Sep 24, 2026 5 AI consumers· 4 recurring
Per the valuechain.wiki graph, STERIS plc is directly linked to 2 companies (0 supply, 1 revenue, 1 investment relationships) and reaches 5 companies within two hops; the links are backed by 7 dated sources, 3 of them primary filings (as of 2026-09-24).
Financials & Segments
- Total revenue · FY2026 total revenue of $5.9359 billion
- Segments · Healthcare · Applied Sterilization Technologies (AST) · Life Sciences
Revenue from
- Insulet Corporation High confidence
Insulet is party to a processing arrangement under which Omnipod devices are sterilized at STERIS facilities. Counterparty-specific spending is not disclosed. - Premier, Inc. Medium confidence
Premier awarded STERIS a group-purchasing contract that made refurbished capital equipment available to member healthcare providers. Individual purchases and total contract value were not disclosed.Confirms EN Premier, Inc. Published Oct 23, 2018: Premier Announces New Supplier Agreements: July, August, September
Pays to
- Nordion High confidence
STERIS procures cobalt-60 used in gamma sterilization under a long-term supply contract with Nordion. The contract value is not publicly disclosed.Mentions KO Fortune Business Insights Published Aug 17, 2026: Sterilization Services Market Size, Share and Industry Analysis, 2034Confirms EN U.S. Federal Trade Commission Published Aug 14, 2015: Reply Memorandum in Support of Plaintiff FTC's Motion for Preliminary Injunction - Raven.ai Medium confidence
STERIS and Cantel plants adopted Raven's digital OEE solution to reduce changeover time and downtime. Software contract value was not disclosed.Confirms EN Raven.ai Published Feb 16, 2023: How STERIS Streamlined Changeovers and Reduced Downtime by 70%
Investments
- Becton, Dickinson and Company High confidence· Amount $540M · FY2024 인수 · Final purchase price for Becton Dickinson surgical-instrument, laparoscopic-instrument, and sterilization-container assets
STERIS acquired surgical instruments, laparoscopic instruments, and sterilization-container assets from Becton Dickinson and integrated them into Healthcare. The final purchase price was $539.8 million.Confirms EN STERIS plc Published Jun 20, 2023: STERIS Expands Healthcare Products Offering with Acquisition of Surgical Instrumentation Assets from Becton, Dickinson and Company
Value-chain ripple (2 tiers)
Following node-to-node links up to 2 tiers; each firm is shown once, at its nearest tier.
| Company | Chain | '21 | '22 | '23 | '24 | '25 | YTD |
|---|---|---|---|---|---|---|---|
| Insulet Corporation | lead1 | +4.1 | +10.6 | -26.3 | +20.3 | +8.9 | -52.4 |
| STERIS plc | node | +29.5 | -23.4 | +20.2 | -5.6 | +24.3 | -14.7 |
| Becton, Dickinson and Company | benef1 | +1.9 | +5.1 | -2.7 | -5.4 | -12.6 | +22.8 |
| Jabil | benef2 | +66.4 | -2.5 | +87.4 | +13.3 | +58.7 | +36.3 |
| Amazon | benef2 | +2.4 | -49.6 | +80.9 | +44.4 | +5.2 | +12 |
| Edwards Lifesciences Corporation | benef2 | +42 | -42.4 | +2.2 | -2.9 | +15.2 | +5.5 |
YTD as of 2026-10-09 · source: Yahoo Finance
STERIS plc operates across Infection prevention and contract sterilization. It is -10.9% in 2026. Its demand and supply links are known, but listed-counterparty return data is limited. Its operations depend on critical inputs such as cobalt-60 and ethylene oxide, manufacturing components, and production-management software.
Analysis generated from returns as of 2026-09-04← All companiesMarkdown · JSON · Customers · Suppliers · Ripple